Press Release February 18, 2021 February 18, 2021 by Barbara Dunford CAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEMENT AND EXIT FROM THE PHARMACEUTICAL DEVELOPMENT BUSINESS